BerGenBio ASA (LON: 0RU5)

BerGenBio ASA Statistics

Total Valuation

BerGenBio ASA has a market cap or net worth of GBP 24.07 million. The enterprise value is 11.48 million.

Market Cap	24.07M
Enterprise Value	11.48M

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+306.33%
Shares Change (QoQ)	+8.97%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	22.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.06
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.71

Current Ratio	4.71
Quick Ratio	4.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -96.83% and return on invested capital (ROIC) is -64.06%.

Return on Equity (ROE)	-96.83%
Return on Assets (ROA)	-52.67%
Return on Capital (ROIC)	-64.06%
Revenue Per Employee	2,461
Profits Per Employee	-719,353
Employee Count	16
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-71.85%
50-Day Moving Average	9.40
200-Day Moving Average	17.58
Relative Strength Index (RSI)	44.96
Average Volume (20 Days)	568

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BerGenBio ASA had revenue of GBP 36,915 and -10.79 million in losses. Loss per share was -0.34.

Revenue	36,915
Gross Profit	36,915
Operating Income	-11.43M
Pretax Income	-10.79M
Net Income	-10.79M
EBITDA	-11.41M
EBIT	-11.43M
Loss Per Share	-0.34

Balance Sheet

Cash & Cash Equivalents	12.39M
Total Debt	n/a
Net Cash	12.39M
Net Cash Per Share	n/a
Equity (Book Value)	10.87M
Book Value Per Share	0.28
Working Capital	10.86M

Cash Flow

Operating Cash Flow	-9.85M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-30,951.04%
Pretax Margin	-29,230.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BerGenBio ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-306.33%
Shareholder Yield	-306.33%
Earnings Yield	-44.83%
FCF Yield	n/a

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	0.01

Scores

BerGenBio ASA has an Altman Z-Score of 6.18.

Altman Z-Score	6.18
Piotroski F-Score	n/a